These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


234 related items for PubMed ID: 477605

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Metergoline and cyproheptadine suppress prolactin release by a non-5-hydroxytryptaminergic, non-dopaminergic mechanism.
    Besser GM, Delitala G, Grossman A, Yeo T.
    Br J Pharmacol; 1980 Sep; 70(1):5-7. PubMed ID: 7426830
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Repeated treatment with d-fenfluramine or metergoline alters cortex binding of 3H-serotonin and serotenergic sensitivity in rats.
    Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F.
    Eur J Pharmacol; 1980 Jan 25; 61(2):203-6. PubMed ID: 7353591
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Serotonergic modulation of footshock induced aggression in paired rats.
    Datla KP, Mitra SK, Bhattacharya SK.
    Indian J Exp Biol; 1991 Jul 25; 29(7):631-5. PubMed ID: 1839019
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effect of two serotonin antagonists on prolactin and thyrotrophin secretion in man.
    Ferrari C, Paracchi A, Rondena M, Beck-Peccoz P, Faglia G.
    Clin Endocrinol (Oxf); 1976 Sep 25; 5(5):575-78. PubMed ID: 991435
    [Abstract] [Full Text] [Related]

  • 34. Preclinical studies on LY237733, a potent and selective serotonergic antagonist.
    Foreman MM, Fuller RW, Nelson DL, Calligaro DO, Kurz KD, Misner JW, Garbrecht WL, Parli CJ.
    J Pharmacol Exp Ther; 1992 Jan 25; 260(1):51-7. PubMed ID: 1731051
    [Abstract] [Full Text] [Related]

  • 35. Exploratory hypoactivity induced by m-trifluoromethylphenylpiperazine (TFMPP) and m-chlorophenylpiperazine (m-CPP).
    Kłodzińska A, Jaros T, Chojnacka-Wójcik E, Maj J.
    J Neural Transm Park Dis Dement Sect; 1989 Jan 25; 1(3):207-18. PubMed ID: 2775468
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Central serotonin agonist actions of LY 165163, 1-(m-trifluoromethylphenyl)-4-(p-aminophenylethyl) piperazine, in rats.
    Fuller RW, Snoddy HD, Molloy BB.
    J Pharmacol Exp Ther; 1986 Nov 25; 239(2):454-9. PubMed ID: 2430093
    [Abstract] [Full Text] [Related]

  • 39. Neuroendocrine evidence for antagonism of serotonin and dopamine receptors by olanzapine (LY170053), an antipsychotic drug candidate.
    Fuller RW, Snoddy HD.
    Res Commun Chem Pathol Pharmacol; 1992 Jul 25; 77(1):87-93. PubMed ID: 1359615
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.